Standardpharm Co., Ltd – Trademark Portfolio

Entity Type: 03

Standardpharm Co., Ltd holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include STDPHARM and STANDARDPHARM. The owner is based in OFFICE 40 ALBANY, NY.

90 STATE STREET SUITE 700,

OFFICE 40 ALBANY, NY 12207

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Standardpharm Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Standardpharm Co., Ltd have?

Standardpharm Co., Ltd has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Standardpharm Co., Ltd file in?

Standardpharm Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Standardpharm Co., Ltd's most well-known trademarks?

Standardpharm Co., Ltd's registered trademark portfolio includes well-known marks such as STDPHARM and STANDARDPHARM. These are among 4 currently registered trademarks in the portfolio.

What is Standardpharm Co., Ltd's trademark registration success rate?

Standardpharm Co., Ltd has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.